GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Sale Of Investment

Chordia Therapeutics (TSE:190A) Sale Of Investment : 円0.00 Mil (TTM As of Aug. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Sale Of Investment?

Chordia Therapeutics's sale of investment for the three months ended in Aug. 2024 was 円0.00 Mil. It means Chordia Therapeutics gained 円0.00 Mil from selling investments. Chordia Therapeutics's sale of investment for the trailing twelve months (TTM) ended in Aug. 2024 was 円0.00 Mil.

Compared with last quarter (円0.00 Mil in Aug. 2023 ), Chordia Therapeutics gained the same money from selling investments in Aug. 2024 (円0.00 Mil).


Chordia Therapeutics Sale Of Investment Historical Data

The historical data trend for Chordia Therapeutics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Sale Of Investment Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Sale Of Investment
- - - -

Chordia Therapeutics Quarterly Data
Aug21 Aug22 Aug23 Aug24
Sale Of Investment - - - -

Chordia Therapeutics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordia Therapeutics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordia Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines